Evidence map›Paper›PMID 30104959›Full record

ArticleFrontiers in molecular neuroscience2018

Trilobatin Protects Against Oxidative Injury in Neuronal PC12 Cells Through Regulating Mitochondrial ROS Homeostasis Mediated by AMPK/Nrf2/Sirt3 Signaling Pathway.

Jianmei Gao, Shuang Liu, Fan Xu, Yuangui Liu, Chun Lv, Yan Deng, Jingshan Shi, Qihai Gong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The roles of sirtuins in ferroptosis.Frontiers in physiology · 2023
    Review
  11. Review
  12. Sirtuin-3: A potential target for treating several types of brain injury.Frontiers in cell and developmental biology · 2023
    Review
  13. Review
  14. Article
  15. Chinese herbal medicines · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jianmei GaoDepartment of Clinical Pharmacotherapeutics, School of Pharmacy, Zunyi Medical University, Zunyi, China.
Shuang LiuDepartment of Pharmacology, Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi, China.
Fan XuDepartment of Clinical Pharmacotherapeutics, School of Pharmacy, Zunyi Medical University, Zunyi, China.
Yuangui LiuDepartment of Pharmacology, Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi, China.
Chun LvDepartment of Pharmacology, Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi, China.
Yan DengDepartment of Pharmacology, Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi, China.
Jingshan ShiDepartment of Pharmacology, Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi, China.
Qihai GongDepartment of Pharmacology, Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi, China.
Zunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress-induced neuronal cell damage is a crucial factor in the pathogenesis of mitochondria-associated neurological diseases. Therefore, elimination of overproduction of mitochondrial reactive oxygen species (mtROS) may be a potential strategy for prevention and treatment of neurological diseases. In the present study, the neuroprotective effects of trilobatin (TLB), a novel small molecule monomer derived from

Indexed as

AMPKhydrogen peroxideNrf2PC12 cellsSirt3trilobatin

Identifiers

PMID30104959
PMCPMC6077207
OpenAlexW2885104140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.